CY1115894T1 - USES OF INTERFERENCE WITH MODIFIED SPACE - Google Patents

USES OF INTERFERENCE WITH MODIFIED SPACE

Info

Publication number
CY1115894T1
CY1115894T1 CY20151100043T CY151100043T CY1115894T1 CY 1115894 T1 CY1115894 T1 CY 1115894T1 CY 20151100043 T CY20151100043 T CY 20151100043T CY 151100043 T CY151100043 T CY 151100043T CY 1115894 T1 CY1115894 T1 CY 1115894T1
Authority
CY
Cyprus
Prior art keywords
interference
hypersensitivity
subject
effective amount
provides
Prior art date
Application number
CY20151100043T
Other languages
Greek (el)
Inventor
Guangwen Wei
Original Assignee
Superlab Far East Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP10193126.9A external-priority patent/EP2325202B1/en
Application filed by Superlab Far East Limited filed Critical Superlab Far East Limited
Publication of CY1115894T1 publication Critical patent/CY1115894T1/en

Links

Abstract

Η παρούσα εφεύρεση παρουσιάζει μια μέθοδο για την πρόληψη ή την αντιμετώπιση του Σοβαρού Οξέος Αναπνευστικού Συνδρόμου σε ένα υποκείμενο, η οποία περιλαμβάνει τη χορήγηση στο υποκείμενο μιας αποτελεσματικής ποσότητας της ανασυνδυασμένης υπερένωσης ιντερφερόνης ή ενός λειτουργικού ισοδύναμου αυτής. Η παρούσα εφεύρεση παρέχει μια μέθοδο για την αναστολή του νοσογόνου παράγοντα του Σοβαρού Οξέος Αναπνευστικού Συνδρόμου που περιλαμβάνει την επαφή του παράγοντα με μια αποτελεσματική ποσότητα της υπερένωσης ιντερφερόνης ή του ισοδυνάμου αυτής.The present invention provides a method for preventing or treating Severe Acute Respiratory Syndrome in a subject, comprising administering to the subject an effective amount of recombinant interferon hypersensitivity or a functional equivalent thereof. The present invention provides a method for inhibiting the Serious Acid Respiratory Syndrome pathogenic agent comprising contacting the agent with an effective amount of interferon hypersensitivity or its equivalent.

CY20151100043T 2003-08-28 2015-01-16 USES OF INTERFERENCE WITH MODIFIED SPACE CY1115894T1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49844903A 2003-08-28 2003-08-28
US49878503A 2003-08-28 2003-08-28
US49892303A 2003-08-28 2003-08-28
IN280MU2004 2004-03-05
IN279MU2004 2004-03-05
EP10193126.9A EP2325202B1 (en) 2003-08-28 2004-08-26 Uses of interferons with altered spatial structure

Publications (1)

Publication Number Publication Date
CY1115894T1 true CY1115894T1 (en) 2017-01-25

Family

ID=58457107

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20141100200T CY1114971T1 (en) 2003-08-28 2014-03-13 USES OF INTERFERENCE WITH MODIFIED SPACE
CY20151100043T CY1115894T1 (en) 2003-08-28 2015-01-16 USES OF INTERFERENCE WITH MODIFIED SPACE

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20141100200T CY1114971T1 (en) 2003-08-28 2014-03-13 USES OF INTERFERENCE WITH MODIFIED SPACE

Country Status (1)

Country Link
CY (2) CY1114971T1 (en)

Also Published As

Publication number Publication date
CY1114971T1 (en) 2016-12-14

Similar Documents

Publication Publication Date Title
CY1121853T1 (en) COMBINATION THERAPY FOR THE MANAGEMENT OF DIABETES
CY1120079T1 (en) Aqueous Composition Containing Bromexine
CY1117033T1 (en) TREATMENT AGAINST ACUTE LEMBLASTIC LEFT
CY1120961T1 (en) ORAL DOSAGE CONTAINERS INCLUDING ANTI-PETROLEUM PATENT AND ACID INHIBITOR
CY1111926T1 (en) COOPERATIVE COMPOSITIONS WITH FK-228
CY1109295T1 (en) METHODS FOR TREATMENT OF PARKINS DISEASE
CY1121125T1 (en) COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS
CY1120022T1 (en) Pediatric Acute Acute Lymphoblastic Leukemia Treatment
EA200601553A1 (en) SUBSTITUTED BENZIMIDAZOLE-, BENZTRIASOLE- AND BENZIMIDAZOLONE-O-GLUCOSIDES
CY1118731T1 (en) ALVIGLUTIDIS PHARMACEUTICAL COMPOSITIONS
CY1119488T1 (en) BASES FOR TREATMENT Ή / AND PREVENTION OF SLEEP DISORDER
EA200870357A1 (en) DERIVATIVES OF TETRAHYDROISOHINOLINE FOR IMPROVING MEMORY FUNCTION
CY1111225T1 (en) NEW Peptides As NS3-Serine Protease Inhibitors Inhibit C
CY1112185T1 (en) STABLE COMPOUND OF ACTIVE SUBSTANCES FROM SALTS OF O-ACETYLSACYLIC ACIDS WITH BASIC AMINO ACIDS AND GLYCIN
EA201500802A1 (en) METHODS OF PREVENTION AND / OR TREATMENT OF CARDIOMYOPATHY AND ELIMINATION OF CARDIOMYOPATHY SYMPTOMS, PHARMACEUTICAL COMPOSITION, VECTORS
MX341883B (en) Pharmaceutical composition for treatment and prevention of cancer.
EA202091114A1 (en) NEW HIGHLY ACTIVE PYRAZOLOPIPERIDINE-SUBSTITUTED INDOL-2-CARBOXAMIDES ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
CY1113485T1 (en) SUBSTITUTED-CINOXALINE TYPES OF POWERED-Piperidine Compounds and Their Uses
CY1119850T1 (en) USE OF METFORMIN IN COMBINATION WITH AN INTERACTIVE GLYKINASE AND COMPOSITIONS INCLUDING METFORMIN AND ACTIVATOR
CY1116374T1 (en) TREATMENT FOR INFECTION WITH USITIS B alone or in combination with USITA virus delta and related US diseases
CY1115081T1 (en) NEW EXTRACT FROM GAIDOURAGATHO, METHOD FOR PREPARATION AND USE
CY1112614T1 (en) TREATMENT WITH TREATMENT FOR MULTIPLE SCLEROSIS
CY1118967T1 (en) HIGH-DOSE BIOTINE PHARMACEUTICAL COMPOSITIONS
EA200702336A1 (en) APPLICATION 24-NorUDK